ULBP2
Basic information
Region (hg38): 6:149942013-149949235
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ULBP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 17 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 2 | 2 |
Variants in ULBP2
This is a list of pathogenic ClinVar variants found in the ULBP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-149942131-C-T | not specified | Uncertain significance (Dec 15, 2021) | ||
6-149945375-C-T | not specified | Uncertain significance (Dec 20, 2023) | ||
6-149945390-T-A | not specified | Uncertain significance (May 18, 2022) | ||
6-149945440-C-G | not specified | Uncertain significance (Jul 11, 2023) | ||
6-149945477-C-T | not specified | Uncertain significance (Oct 02, 2023) | ||
6-149945498-C-G | not specified | Uncertain significance (Mar 15, 2024) | ||
6-149945539-C-G | not specified | Uncertain significance (Mar 31, 2024) | ||
6-149946451-C-T | Likely benign (Apr 10, 2018) | |||
6-149946465-T-C | not specified | Uncertain significance (Oct 26, 2022) | ||
6-149946494-T-C | not specified | Uncertain significance (Jun 07, 2023) | ||
6-149946501-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
6-149946519-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
6-149946535-G-T | not specified | Uncertain significance (Dec 27, 2023) | ||
6-149946552-T-C | not specified | Uncertain significance (Aug 29, 2022) | ||
6-149946566-T-C | not specified | Likely benign (Aug 13, 2021) | ||
6-149946584-G-A | not specified | Uncertain significance (Aug 16, 2022) | ||
6-149946590-T-C | not specified | Uncertain significance (Nov 06, 2023) | ||
6-149946591-G-A | not specified | Uncertain significance (Dec 06, 2022) | ||
6-149946621-G-A | not specified | Uncertain significance (Dec 12, 2022) | ||
6-149946641-C-A | not specified | Uncertain significance (Dec 08, 2023) | ||
6-149947338-C-T | Benign (Jul 20, 2018) | |||
6-149947356-G-A | not specified | Uncertain significance (Dec 31, 2023) | ||
6-149947397-A-C | Benign (Jul 20, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ULBP2 | protein_coding | protein_coding | ENST00000367351 | 4 | 7236 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.84e-9 | 0.0361 | 125721 | 0 | 24 | 125745 | 0.0000954 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -1.36 | 168 | 125 | 1.34 | 0.00000639 | 1583 |
Missense in Polyphen | 34 | 21.432 | 1.5864 | 333 | ||
Synonymous | -0.246 | 50 | 47.8 | 1.05 | 0.00000258 | 487 |
Loss of Function | -0.731 | 12 | 9.56 | 1.26 | 4.13e-7 | 120 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00109 | 0.00109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00109 | 0.00109 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds and activates the KLRK1/NKG2D receptor, mediating natural killer cell cytotoxicity. {ECO:0000269|PubMed:11777960}.;
- Pathway
- Natural killer cell mediated cytotoxicity - Homo sapiens (human);Post-translational modification: synthesis of GPI-anchored proteins;Post-translational protein modification;Metabolism of proteins
(Consensus)
Recessive Scores
- pRec
- 0.0999
Intolerance Scores
- loftool
- rvis_EVS
- 0.39
- rvis_percentile_EVS
- 76.05
Haploinsufficiency Scores
- pHI
- 0.317
- hipred
- N
- hipred_score
- 0.112
- ghis
- 0.388
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.592
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ulbp1
- Phenotype
Gene ontology
- Biological process
- T cell mediated cytotoxicity;immune response;viral process;natural killer cell activation;natural killer cell mediated cytotoxicity;susceptibility to natural killer cell mediated cytotoxicity
- Cellular component
- extracellular region;extracellular space;endoplasmic reticulum;plasma membrane;external side of plasma membrane;cell surface;anchored component of plasma membrane
- Molecular function
- protein binding;natural killer cell lectin-like receptor binding